Logo

News & Events

Latest News

May 9, 2022
Apexigen to Host Investor Day on Antibody Therapeutic Pipeline and Unique APXiMAB™ Platform

April 12, 2022
Apexigen Announces New Data from a Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Pembrolizumab in Patients with Metastatic Melanoma Presented at the AACR Annual Meeting 2022

April 7, 2022
Apexigen Announces That New Data From Phase 2 Trial Evaluating its CD40 Antibody Sotigalimab in Combination With Pembrolizumab in Patients With Metastatic Melanoma Will Be Presented at the AACR Annual Meeting 2022

March 18, 2022
Apexigen and Brookline Capital Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Immuno-oncology Company

January 4, 2022
Apexigen Announces Appointment of Francis Sarena as Chief Operating Officer


View all Press Releases

Presentations

March 16, 2022
Investor Day Presentation

Upcoming Events

There are no upcoming events at this time.

Past Events

May 16, 2022
Apexigen Investor Day

March 18, 2022
Apexigen Conference Call
Link to webcast

January 5-7, 2022
LifeSci Partners Corporate Access Event

November 30, 2021
Evercore ISI’s HealthCONx Conference

November 17, 2021
Stifel Virtual Healthcare Conference

November 9, 2021
Key Opinion Leader Webinar on Sotigalimab
Click to play recording of webinar

  • Home
  • About
  • Pipeline
  • Science
  • Collaborations
  • News & Events
  • Careers
  • Contact
  • Terms of Use
  • Home
  • About
  • Pipeline
  • Science
  • Collaborations
  • News & Events
  • Careers
  • Contact
© 2022 ApexigenAll rights reserved
  • Terms of Use
Website Design: Hane Chow, Inc.